Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Sirnaomics Ltd. ( (HK:2257) ) has issued an announcement.
Sirnaomics Ltd. announced the subscription of 17,352,421 new shares under a general mandate, priced at HK$12.00 per share. This move, which does not require shareholder approval, represents approximately 16.50% of the company’s existing issued share capital and aims to enhance the company’s financial position, potentially impacting its market presence and stakeholder interests.
The most recent analyst rating on (HK:2257) stock is a Hold with a HK$8.50 price target. To see the full list of analyst forecasts on Sirnaomics Ltd. stock, see the HK:2257 Stock Forecast page.
More about Sirnaomics Ltd.
Sirnaomics Ltd. is a biotechnology company incorporated in the Cayman Islands, focusing on the development of RNAi therapeutics. The company is listed on the Hong Kong Stock Exchange and is engaged in advancing innovative treatments for various diseases.
Average Trading Volume: 940,164
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.57B
See more insights into 2257 stock on TipRanks’ Stock Analysis page.